SNHG3 and bladder transitional cell carcinoma: Then, we constructed SNHG3 knockdown plasmids using CRISPR‐CAS9 technology and packaged them with lentiviruses, and then infected T24 and J82 with lentiviruses to construct BLCa cell lines that stably knocked down SNHG3.